Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 3

NCT06553768

Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participants who have…

United States90 participantsStarted 2024-10-14

Treatment: Maralixibat, Placebo